Development of an Economic Model to Assess the Cost Effectiveness of Asthma Management Strategies
- 1 January 2002
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 20 (3) , 183-194
- https://doi.org/10.2165/00019053-200220030-00004
Abstract
Background and objective:Asthma is a chronic-episodic disease characterised by acute, symptomatic episodes of varying severity. We developed a Markov model that can be used to estimate the cost...Keywords
This publication has 12 references indexed in Scilit:
- Is overall asthma control being achieved? A hypothesis-generating studyEuropean Respiratory Journal, 2001
- Representing Both First- and Second-order Uncertainties by Monte Carlo Simulation for Groups of PatientsMedical Decision Making, 2000
- Handling Uncertainty in Cost-Effectiveness ModelsPharmacoEconomics, 2000
- The Cost Implications of an Asthma AttackPediatric Asthma, Allergy & Immunology, 1998
- An Introduction to Markov Modelling for Economic EvaluationPharmacoEconomics, 1998
- The costs of asthmaEuropean Respiratory Journal, 1996
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- An Economic Evaluation of Asthma in the United StatesNew England Journal of Medicine, 1992
- Probabilistic sensitivity analysis methods for general decision modelsComputers and Biomedical Research, 1986
- Probabilistic Sensitivity Analysis Using Monte Carlo SimulationMedical Decision Making, 1985